日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Application given for gene therapy trials to treat blood disease

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-01-19 14:44
Share
Share - WeChat
A screenshot from EdiGene's official website. [Photo/edigene.com]

Chinese biotech company EdiGene Inc announced on Monday the Center for Drug Evaluation of the China National Medical Products Administration has approved the company's Investigational New Drug application for ET-01, a CRISPR/Cas 9 gene-editing therapy for patients with transfusion dependent β-thalassemia, a blood disease characterized by severe anemia and a lifelong dependence on red blood cell transfusions that can lead to iron overload.

That marks the first gene-editing therapy and the first hematopoietic stem cell therapy IND application approval in China.

The Beijing-based company develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases. Previously, the company announced the acceptance of the IND by CDE on Oct 27, 2020.

Wei Dong, CEO of EdiGene, said the company will roll out phase I clinical trials soon.

"We are embarking on a new journey as a clinical-stage company. We will continue to translate cutting-edge gene-editing technology and advance our pipeline, with a goal of providing better choices for patients in China and around the world," he said.

ET-01 is an investigational, autologous, ex vivo gene-editing therapy. The approved trial of ET-01 is a multicenter, open-label, single arm study designed to assess safety and efficacy in transfusion dependent β-thalassemia patients.

In China, it is estimated there are over 300,000 patients with thalassemia major or thalassemia intermediate. Serious unmet medical needs remain for transfusion dependent β-thalassemia patients today.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲精品三级 | 亚洲激情小视频 | 欧美jlzz18性欧美 | 男人天堂99 | 欧美一区二区三区国产精品 | 强伦女教师视频 | 国产区视频在线观看 | 成人午夜在线视频 | 日韩中文一区二区三区 | 欧美性高清视频免费看www | 激情五月色综合色婷婷 | 2019中文字幕视频 | 嫩草91| 亚洲一区二区在线播放 | 日本 欧美 国产 | 另类国产ts人妖高潮系列视频 | 91成人免费电影 | 特级黄一级播放 | 亚洲欧美国产精品久久久久久久 | 亚洲一区二区三区免费观看 | 亚洲欧美成人综合在线 | 97超级碰碰碰视频在线视频观看 | 九九热线有精品视频99 | 成人免费视频网站在线观看 | 国产精品蜜臂在线观看 | 亚洲视频在线观看免费视频 | 99久在线视频| 免费一级毛片在线播放欧美 | 国产亚洲精品久久久久久久网站 | 波多野结衣hd在线播放 | 中国大陆高清aⅴ毛片 | 九九九九精品视频在线播放 | 国产精品99久久久久久久女警 | 夜夜夜爽bbbb性视频 | 国产一区二区三区久久久久久久久 | 黄色网址进入 | 亚洲欧美一区二区三区情侣bbw | 傲视影院午夜毛片 | 韩国在线精品福利视频在线观看 | 久久久久久国产精品免费免费 | 日日噜噜夜夜狠狠视频buoke |